Despite their potential, nanotherapeutics face several challenges, including:
Biocompatibility: Ensuring that nanomaterials are non-toxic and do not elicit adverse immune responses. Scalability: Developing cost-effective and scalable manufacturing processes for consistent production. Regulatory approval: Navigating complex regulatory pathways to ensure safety and efficacy. Long-term effects: Understanding the long-term biodistribution, metabolism, and potential toxicity of nanotherapeutics.
